Baden

Lindsey Robert Baden, MMSc, MD

Lab Info:

Principal Investigator: Lindsey Robert Baden, MMSc, MD

Office/Location: 75 Francis Street, PBB-A-4

Phone: (617) 732-8881

Email: lbaden@partners.org

Category: Associate Members

Lindsey R. Baden is the Director of Clinical Research in the Division of Infectious Diseases at the Brigham and Women’s Hospital, as well as the Director of Infectious Diseases at the Dana-Farber Cancer Institute. He also holds the appointment of Associate Professor at the Harvard Medical School, all in Boston, Massachusetts. He received his medical school training at the Albert Einstein College of Medicine, followed by a residency in Internal Medicine at the Beth Israel Hospital in Boston. He completed a Fellowship at the Beth Israel and Brigham and Women’s Hospital in Infectious Diseases and is board certified in Infectious Diseases and Internal Medicine. His current research interests focus on the impact of infection in the immunocompromised host (primarily recipients of hematopoietic stem-cell transplants).

 

Selected Publications

1. Walsh SR, Seaman MS, Grandpre LE, Charbonneau C, Yanosick KE, Metch B, Keefer MC, Dolin R, Baden LR. Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 2012 Dec 17; 31(1):114-9.

2. Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marr KA, Montoya JG, Morris-Engemann A, Pappas PG, Rolston K, Segal B, Seo SK, Swaminathan S, Naganuma M, Shead DA. Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw. 2012 Nov 1; 10(11):1412-45.

3. Issa NC, Baden LR. Current issues in vaccines for adult patients with hematologic malignancies. J Natl Compr Canc Netw. 2012 Nov 1; 10(11):1447-54.

4. Koo S, Kubiak DW, Issa NC, Dietzek A, Boukedes S, Camp PC, Goldberg HJ, Baden LR, Fuhlbrigge AL, Marty FM. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis. Transplantation. 2012 Aug 15; 94(3):281-6.

5. Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O’Reilly RJ, Soiffer RJ. Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation. J Clin Oncol. 2012 Sep 10; 30(26):3194-201.

6. Hammond SP, Gagne LS, Stock SR, Marty FM, Gelman RS, Marasco WA, Poritz MA, Baden LR. Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods. J Clin Microbiol. 2012 Oct; 50(10):3216-21.

7. Cohen MS, Baden LR. Preexposure prophylaxis for HIV–where do we go from here? N Engl J Med. 2012 Aug 2; 367(5):459-61.

8. Knoll BM, Kappagoda S, Gill RR, Goldberg HJ, Boyle K, Baden LR, Fuhlbrigge AL, Marty FM. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis. 2012 Oct; 14(5):452-60.

9. Hill JA, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J, Armand P, Alyea EP, Baden LR, Antin JH, Soiffer RJ, Marty FM. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant. 2012 Nov; 18(11):1638-48.

10. Kubiak DW, Koo S, Hammond SP, Armand P, Baden LR, Antin JH, Marty FM. Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. Biol Blood Marrow Transplant. 2012 Sep; 18(9):1462-5.